Valneva Se's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 30.36, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Valneva Se in Dec 31 2025 quarter, has decreased to 12 days, compared to 14 days, in the 0 quarter.

If we take a look into Healthcare sector 354 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 2483.

What is Receivable Turnover Ratio?
What is Valneva Se Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VALN Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-10.65 %	-	-	-	-20.91 %
Y / Y Revenue Change	3 %	-	-	45.83 %	10.32 %
Receivable Turnover Ratio (TTM)	30.36	26.5	26.5	26.5	24.71
VALN's Total Ranking	# 2483	# 0	#	#	#
Accounts Receivable average collection period days	12	14	14	14	15
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-72.7 %	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 24
Healthcare Sector	# 355
Overall Market	# 2483

Receivable Turnover Ratio Statistics
High	Average	Low
0.58	0.42	0.33
(Dec 31 2022)		(Dec 31 2023)

VALN Company Profile • Back to VALN Efficiency Comparisons • Compare VALN Receivables Turnover Ratio to its Competitors

Financial Statements
Valneva Se's Accounts Receivable	$ 33 Millions	Visit VALN's Balance sheet
Valneva Se's Sales TTM	$ 247 Millions	Visit VALN's Income Statement
Sources of VALN's Revenues		Visit VALN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VALN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VALN's Growth Rates	VALN's Roa	VALN's Inventory Turnover Ratio	VALN's Dividend Comparisons
VALN's Profitability Ratios	VALN's Roi	VALN's Asset Turnover Ratio	VALN's Dividend Growth
VALN's Valuation Ratios	VALN's Roe	VALN's Financial Strength Ratios	VALN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Voyager Therapeutics Inc	19.59	$ 40.374 Millions	$ 2.061 Millions
Sonida Senior Living Inc	19.55	$ 381.141 Millions	$ 19.494 Millions
Siga Technologies Inc	19.47	$ 94.575 Millions	$ 4.856 Millions
Kiniksa Pharmaceuticals International Plc	19.45	$ 677.564 Millions	$ 34.828 Millions
Wave Life Sciences Ltd	18.34	$ 59.102 Millions	$ 3.223 Millions
Vystar Corporation	18.31	$ 0.055 Millions	$ 0.003 Millions
Arbutus Biopharma Corp	18.10	$ 14.083 Millions	$ 0.778 Millions
Scinai Immunotherapeutics Ltd	17.96	$ 1.311 Millions	$ 0.073 Millions
Nurix Therapeutics Inc	17.68	$ 83.980 Millions	$ 4.750 Millions
Bioharvest Sciences Inc	17.42	$ 34.508 Millions	$ 1.981 Millions
Cue Biopharma Inc	16.99	$ 27.466 Millions	$ 1.616 Millions
Bioage Labs Inc	16.01	$ 8.995 Millions	$ 0.562 Millions
Nutriband Inc	15.64	$ 2.037 Millions	$ 0.130 Millions
China Pharma Holdings Inc	15.58	$ 4.144 Millions	$ 0.266 Millions
Talkspace Inc	15.35	$ 228.871 Millions	$ 14.915 Millions
Vaxart Inc	15.05	$ 237.258 Millions	$ 15.765 Millions
Precipio inc	15.02	$ 24.049 Millions	$ 1.601 Millions
Innoviva Inc	14.98	$ 384.667 Millions	$ 25.683 Millions
Nanobiotix S a	14.70	$ 36.850 Millions	$ 2.507 Millions
Silence Therapeutics Plc	14.52	$ 0.559 Millions	$ 0.039 Millions
Qhslab Inc	14.47	$ 2.692 Millions	$ 0.186 Millions
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
10x Genomics Inc	13.28	$ 641.881 Millions	$ 48.330 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
Skinhealth Systems Inc	13.02	$ 300.364 Millions	$ 23.063 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions

Date modified: 2026-07-07T14:02:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.